The association of tobacco use and body weight has long been a matter of concern. In 2004, I collaborated with Swedish investigators to publish the first research on whether switching from cigarettes to smokeless tobacco blunts some of the weight gain normally seen with quitting via abstinence (abstract here, blog post here).
As a pathologist working at two large medical centers, I have studied the effects of smoking on health for over 20 years. I’ve published scores of papers on the impressive benefits of switching from cigarettes to safer, non-combustible forms of tobacco (such as Swedish snus). This strategy – called tobacco harm reduction – has vast potential for improving public health.
The New York Times has added more fuel to the anti-tobacco-harm-reduction fire with a December 4 editorial (here) rehashing the somewhat slanted reporting that appeared in the paper’s news pages on November 30. In two stories that day, the Times explored issues surrounding Swedish Match’s FDA application to change the warnings on its snus products. As I noted (here), “The Times and their quoted experts did a major disservice to their audience; they failed to report the simple truth, that mouth cancer risk for Swedish snus is next to nil.”
The New York Times has published (here) a reasonably accurate portrayal of the Swedish snus experience that I have chronicled for over a decade (here, here, andhere). Reporters Matt Richtel and David Jolly examined Swedish Match’s FDA application to remove the federally mandated mouth cancer and not-safe-alternative warnings from snus products. I have discussed this landmark filing previously (here).
Swedish researchers from several institutions document that snus use is not associated with atrial fibrillation (commonly known as AFib), the most common heart arrhythmia (irregular timing of the heart beat) and a risk factor for stroke (abstract here). The same group previously reported that snus use conferred no significant risk for heart attack (discussed here) and stroke (here).
TweetBrad Rodu, Endowed Chair, Tobacco Harm Reduction Research at the University of Louisville and Senior Fellow at the Heartland Institute discusses tobacco harm reduction on “The Legislature Today’ radio show[…]
Tweet[First published Sept. 30 in The Oklahoman.] A quit-smoking strategy with “the potential to save millions of lives” will be the subject of an Oklahoma legislative hearing Wednesday. At issue[…]
TweetDr. Brad Rodu, senior fellow at The Heartland Institute, testified on Wednesday, September 19 before the Indiana General Assembly’s Health Finance Commission on tobacco harm reduction. His appearance — in which[…]